Bosch Healthcare Solutions GmbH
Vivalytic Bacterial Meningitis by Bosch: PCR rapid test for medical emergencies
mehr
Storys zum Thema Gesundheit / Medizin
- Sprache:
- Medien:
- Zeitraum:
- Zeitraum:Gesamt
Grünenthal appoints Prof. Dr. Uli Brödl as Chief Scientific Officer
mehrNorgine submits Marketing Authorisation Application to the European Medicines Agency for eflornithine (difluoromethylornithine [DFMO]) in high-risk neuroblastoma
London (ots/PRNewswire) - Back to media releases Next media release Norgine today announced that it completed its marketing authorisation application filing to European Medicines Agency (EMA) for eflornithine in high-risk neuroblastoma (HRNB). This follows the submissions in April 2024, via Project Orbis, in ...
mehrRHEACELL receives EMA approval for allo-APZ2-CVU Phase 3 trial in chronic venous ulcers
mehrGerresheimer: FDA grants Tentative Approval of SQ Innovation’s Lasix® ONYU*
mehrAccord Healthcare is granted marketing authorisation for IMULDOSA®, ustekinumab biosimilar to Stelara®
London (ots/PRNewswire) - - Accord announces that the European Commission (EC has granted marketing authorisation for Imuldosa® (development code: DMB-3115), a biosimilar to Stelara®, indicated for a range of immune medicated inflammatory diseases. - The EC approval follows a positive opinion issued on 19 October ...
mehr
25The Future of Nutrition: Dr. Clemens Röhrl on Regional Plant Research and Its Importance for Health and the Environment
mehrStrides Pharma International AG
Strides Pharma Consolidates European Business-to-Business Operations in Switzerland
mehrEuropean Alliance Against Depression
First European Patient Congress Depression for those affected by depression and their close relations takes place online on December 7, 2024 / Free online-event offers information and experience-sharing
Frankfurt am Main (ots) - The European Patient Congress Depression, hosted by the European Alliance Against Depression (EAAD), will take place on December 7, 2024. This free online-event is designed to support individuals affected by depression and their relatives, providing a platform for expert guidance, patient ...
mehr- 2
SHL Medical announces plans to establish SHL Advantec
mehr Grünenthal and Averitas Pharma announce completion of recruitment for Phase III clinical trial with QUTENZA® in post-surgical neuropathic pain
Aachen, Germany/Morristown, N.J. (ots) - - The Phase III trial AV001 aims to evaluate QUTENZA® in post-surgical neuropathic pain (PSNP), a debilitating complication of surgery occurring after approximately 10 percent of all surgical procedures[1], thus affecting more than 3 million people with surgical procedures ...
mehrFirst participants enrolled in first-in-human Phase I clinical trial with nociceptin (NOP) receptor agonist
Aachen, Germany (ots) - Today, Grünenthal announced that the first participants have been enrolled in a first-in-human Phase I clinical trial for a nociceptin (NOP) receptor agonist. The trial will include 90 healthy volunteers and aims to demonstrate a favourable safety and tolerability profile and to confirm the ...
mehrBetter Health Requires More Participation by Young People
Berlin/Gütersloh (ots) - At this year’s World Health Summit in Berlin, the WHO Youth Council presented its vision for healthier societies. The World Health Organization’s Youth Council is calling on policymakers to better leverage the potential of young people. The Bertelsmann Stiftung and major youth organizations support the initiative. Better involvement of and support for young people is essential to creating a ...
mehrNorgine Announces Appointment of New CEO Janneke van der Kamp
London (ots/PRNewswire) - Norgine (the "Company"), a leading European specialty pharmaceutical company, has today announced the appointment of Janneke van der Kamp as its new Chief Executive Officer (CEO), effective from 1 January 2025. Current CEO, Chris Bath, has stepped down from his role effective immediately. This change in leadership will support and enhance the Company's mission of bringing transformative medicines ...
mehrSuccessful MDR Certification for AI Solution in Predicting Postoperative Complications – New Product Generation for Optimized Patient Safety
Berlin (ots) - x-cardiac, a leader in AI-based medical devices for the prediction of postoperative complications after cardiac surgery, is pleased to announce the successful MDR (Medical Device Regulation) certification of its new x-cardiac-platform. This certification introduces a completely new generation of ...
mehrGerman Federal Chancellor Scholz, WHO Director-General Dr Tedros and Bill Gates at the World Health Summit 2024 / The world's leading global health conference begins on October 13
Berlin (ots) - The financing of WHO, Germany's role in global health, antimicrobial resistance, Mpox, digitalization - topics like these are on the agenda of this year's World Health Summit from October 13-15 in Berlin. Leading international experts and decision-makers from all sectors will discuss strategies for a ...
mehrRHEACELL announces FDA approval for Phase 3 study in refractory, non-curable CVU
mehrWort & Bild Verlagsgruppe - Unternehmensmeldungen
You.com and Wort & Bild Verlag Join Forces to Increase Health Information Access with AI
mehrBosch Healthcare Solutions GmbH
Near-patient PCR rapid test for whooping cough for Vivalytic by Bosch now available / World's first fully automated PCR test for detection of B. pertussis, B. parapertussis, B. holmesii
mehrAcousia Therapeutics to present its clinical Phase 2 PROHEAR study on hearing loss treatment candidate ACOU085 at upcoming conferences
Tübingen, Germany (ots) - Acousia Therapeutics GmbH, a Tübingen-based clinical stage biotech company focused on the enhancement and preservation of natural hearing, will be presenting the ACOU085 Phase 2 PROHEAR clinical study at the HansonWade 4th Inner Ear Disorders Therapeutics Summit in Boston (MA) from August ...
mehrGermany Attracts Another Billion-Euro Pharma Project
Berlin (ots) - French pharmaceutical giant Sanofi has confirmed it will invest 1.3 billion euros to expand insulin production in the western German city of Frankfurt am Main. Sanofi says the expansion will encompass around 36,000 square meters – the equivalent of five football fields – on the company’s existing BioCampus site. It will go operational in 2029. The project is being supported by the German national ...
mehrFitLine becomes Official Partner of the ATP Tour
mehrARTCLINE successfully completes capital increases of EUR 4.4 million
Rostock, Germany (ots) - Today ARTCLINE GmbH announced the successful completion of two further capital increases. In addition to the founders, in particular family offices from Germany participated in the first capital increase of EUR 0.8 million. In addition, a convertible loan from investors was transferred to equity, so that a second capital increase of EUR 3.6 ...
mehrResearch Success in Rare Disease / RHEACELL receives positive signal for accelerated stem cell development program in rare ‚Butterfly Disease‘
mehrRHEACELL announces “First Patient In”: EB-Haus in Salzburg, Austria starts pivotal study for stem cell therapy for severe forms of Epidermolysis bullosa that is longed for by those affected
mehrThe Medias Hospital is Raising the Bar for Interventional Oncology as an IASIOS Enrolled Centre
Burghausen/Germany (ots) - The Medias Hospital has officially enrolled in the accreditation program of IASIOS to further ensure highest quality standards in Interventional Oncology as an important aspect of oncological patient care. The Medias Hospital has taken the next step to committing to the highest standards when it comes to interventional oncology (IO) care and ...
mehrSuccessful transaction: Adragos Pharma has officially taken over Clinigen’s development unit, Lamda Laboratories near Athens, Greece
Munich / London / Athens (ots) - - Adragos on a growth path: Three locations in Europe and five globally - Acquisition strengthens Adragos' end-to-end integrated pharmaceutical product development service offering - Agreement on further product development activities for Clinigen Munich-based pharmaceutical contract ...
mehrThe world's first Extended Isolated Stopflow Limb Infusion (EISLI) to treat osteosarcoma results in complete remission
mehrSuccessful transaction: Adragos Pharma has officially taken over the Sanofi production site in Kawagoe, Japan
Munich / Paris / Tokyo (ots) - - Adragos Pharma now third largest pure-play CDMO in the Japanese market - Long-term agreement with Sanofi secures local healthcare supply Munich-based pharmaceutical contract manufacturer (CDMO) Adragos Pharma GmbH successfully completed the acquisition of one of Japan's leading ...
mehrMadeira's public health service SESARAM, EPERAM cooperates with EU project Smart4Health
Potsdam (Germany) (ots) - - Over 260,000 residents and travelers to Madeira Islands can use the digital health solution free of charge - Easy access to healthcare data from the public healthcare services, via a European electronic health record - the Smart4Health platform The Public Health Service of the Autonomous Region of Madeira - SESARAM, EPERAM - has successfully ...
mehr
Vorherige12345678910Nächste